ILMN Illumina, Inc.
Permanent stock page ↗Health Care · S&P 500
Next earnings: not announced yet
What 22 analyst firms say about Illumina, Inc: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
22 rated views · 23 analyst/firm records · 22 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8022
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8015
Recent analyst activity · last 90 days
Our tracked history has 19 reports on ILMN from 18 analyst firms in the last 90 days (22 firms in the past year).
Comparing each firm's latest target with its previous one: 10 raised their price target, 1 lowered it, 1 left it unchanged and 3 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Citigroup raised its target from $113.00 (set 3 Aug 2026) to $210.00 on 2 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | Jasper Hellweg | Buy | 3 Sep 2026 | 235.00 USD |
| Baird | Catherine W Schulte | Hold | 28 Oct 2026 | 286.00 USD |
| Barclays | Luke Sergott | Sell | 7 Oct 2026 | 200.00 USD |
| Bernstein | Eve Burstein | Hold | 26 Sep 2026 | Conflicting reports · excluded |
| Canaccord Genuity | Kyle Mikson | Hold | 19 Oct 2026 | 300.00 USD |
| Citigroup | Joanne K Wuensch | Sell | 31 Jul 2026 | 113.00 USD |
| Citigroup | Patrick Donnelly | Sell | 3 Aug 2026 | 113.00 USD |
| Daiwa | Narumi Nakagiri | Buy | 14 May 2026 | Conflicting reports · excluded |
| Deutsche Bank | Unnamed analyst | Hold | 5 Aug 2026 | — |
| Evercore ISI | Vijay Kumar | Buy | 7 Oct 2026 | 290.00 USD |
| Freedom Capital Markets | Ilya Zubkov | Hold | 5 Aug 2026 | 185.00 USD |
| Guggenheim | Subbu Nambi | Buy | 1 Oct 2026 | 305.00 USD |
| Jefferies | Tycho W Peterson | Hold | 30 Oct 2026 | 235.00 USD |
| JPMorgan | Casey Woodring | Buy | 30 Oct 2026 | 300.00 USD |
| Leerink Partners | Puneet Souda | Buy | 29 Sep 2026 | 300.00 USD |
| Piper Sandler | David Westenberg | Buy | 28 Sep 2026 | 305.00 USD |
| RBC Capital Markets | Dan Leonard | Buy | 5 Oct 2026 | 310.00 USD |
| Stephens | Mason Carrico | Hold | 23 Oct 2026 | 275.00 USD |
| Stifel | Daniel Arias | Buy | 31 Jul 2026 | 225.00 USD |
| TD Cowen | Dan Brennan | Hold | 13 Oct 2026 | 270.00 USD |
| UBS | Doug Schenkel | Buy | 9 Sep 2026 | Conflicting reports · excluded |
| Weiss Ratings | Unnamed analyst | — | 31 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 1 Sep 2026 | 287.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:56 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.